John David Bisognano MD, PhD

Dr. John Bisognano is a Clinical Professor of Internal Medicine and Interim Chief of the Division of Cardiovascular Medicine. Dr. Bisognano earned his bachelor's degree from MIT, his MA in chemistry and Ph.D. in physical chemistry from SUNY-Binghamton University, and his MD from SUNY-Upstate Medical College. Dr. Bisognano completed his internal medicine residency at the University of Michigan where his interest in cardiology and hypertension was ignited by Dr. Stevo Julius. After completing a fellowship in hypertension, Dr. Bisognano moved to Colorado to complete a fellowship in cardiology and advanced heart failure and transplant at the University of Colorado.

Dr. Bisognano returned to the University of Michigan where he was an Assistant Professor of Internal Medicine for several years before joining the new heart transplant team at the University of Rochester in 2001. While there, he served in numerous leadership roles, including Director of Cardiac Rehabilitation, Medical Director of the University’s Accountable Care organization, and Director of Outpatient Cardiology. In 2021, Dr. Bisognano returned to the University of Michigan and joined the faculty in the Division of Cardiovascular Medicine as a clinical professor. He was named the division's interim chief in 2023.

Dr. Bisognano sees patients in the inpatient cardiology services, the inpatient consultative service, and in outpatient clinics. His area of specialty includes general cardiology, as well as severe and resistant hypertension, lipid management, and management of patients with chronic heart failure and ischemic coronary and vascular disease.

A significant part of Dr. Bisognano’s career has been dedicated to general cardiology. He has a longstanding interest in severe and refractory hypertension including device-based therapies for hypertension and is the author of more than 115 journal articles, three books, and numerous book chapters. Dr. Bisognano has served as PI on an NIH R01 grant related to behavioral interventions in people with mild hypertension. He currently serves as a co-investigator on an NIH R61/R33 grant for community-based interventions in hypertension.

Dr. Bisognano has served as President of the American Society of Hypertension, Vice-Chair of the American Heart Association Council on High Blood Pressure, Upstate New York State Governor of the American College of Cardiology, and President of the New York Cardiovascular Society.